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Abstract
We previously reported that autosomal recessive demyelinating Charcot-Marie-Tooth (CMT) type 4B1 neuropathy with
myelin outfoldings is caused by loss of MTMR2 (Myotubularin-related 2) in humans, and we created a faithful mouse
model of the disease. MTMR2 dephosphorylates both PtdIns3P and PtdIns(3,5)P2, thereby regulating membrane
trafficking. However, the function of MTMR2 and the role of the MTMR2 phospholipid phosphatase activity in vivo in the
nerve still remain to be assessed. Mutations in FIG4 are associated with CMT4J neuropathy characterized by both axonal
and myelin damage in peripheral nerve. Loss of Fig4 function in the plt (pale tremor) mouse produces spongiform
degeneration of the brain and peripheral neuropathy. Since FIG4 has a role in generation of PtdIns(3,5)P2 and MTMR2
catalyzes its dephosphorylation, these two phosphatases might be expected to have opposite effects in the control of
PtdIns(3,5)P2 homeostasis and their mutations might have compensatory effects in vivo. To explore the role of the MTMR2
phospholipid phosphatase activity in vivo, we generated and characterized the Mtmr2/Fig4 double null mutant mice. Here
we provide strong evidence that Mtmr2 and Fig4 functionally interact in both Schwann cells and neurons, and we reveal
for the first time a role of Mtmr2 in neurons in vivo. Our results also suggest that imbalance of PtdIns(3,5)P2 is at the basis
of altered longitudinal myelin growth and of myelin outfolding formation. Reduction of Fig4 by null heterozygosity and
downregulation of PIKfyve both rescue Mtmr2-null myelin outfoldings in vivo and in vitro.
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Introduction
Phosphoinositides (PIs) constitute potent signaling molecules
with a specific and restricted distribution at intracellular
membranes that is strictly controlled by the concerted action of
kinases and phosphatases [1,2]. PIs are key regulators of
membrane trafficking as they contribute to assembly of molecular
machineries that promote and control membrane dynamics and
vesicle movement, tethering and fusion. In the nervous system,
both neurons and glia rely on efficient membrane trafficking for
many functions, such as axonal transport or myelination.
Charcot-Marie-Tooth (CMT) neuropathies are very hetero-
geneous disorders from both the clinical and genetic point of
view [3–6]. Several CMT genes encode proteins that regulate
or are connected with PI metabolism, including FRABIN/
FGD4, FIG4, DNM2, RAB7, SIMPLE, LRSAM1, SH3TC2,
MTMR2, and MTMR13, supporting the idea that regulation
of intracellular trafficking is a key process in peripheral
nervous system biology [7] (http://www.molgen.ua.ac.be/
CMTMutations/default.cfm).
We first demonstrated that loss of function mutations in the
MTMR2 (Myotubularin-related 2) gene cause autosomal recessive
demyelinating Charcot-Marie-Tooth type 4B1 (CMT4B1, OMIM
#601382) neuropathy with myelin outfoldings [8]. MTMR2 is a
phospholipid phosphatase that dephosphorylates both PtdIns3P
and PtdIns(3,5)P2 phosphoinositides at the D3 position of the
inositol ring, thus generating PtdIns5P [9–16]. We have generated
a Mtmr2-null mouse which models the CMT4B1 neuropathy and
we reported that loss of Mtmr2 specifically in Schwann cells is
both sufficient and necessary to provoke myelin outfoldings
[17,18]. We recently identified a potential mechanism using in
vivo and in vitro models of CMT4B1 and proposed that Mtmr2
belongs to a molecular machinery that titrates membrane
formation during myelination. According to this model, myelin
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the amount of membrane produced during myelination [19].
Despite these findings, the function of MTMR2 and the role of the
MTMR2 phospholipid phosphatase activity in the nerve still
remain to be assessed.
Loss of the FIG4/SAC3 phospholipid phosphatase in human
provokes another form of autosomal recessive demyelinating
CMT, the CMT type 4J (OMIM #611228) neuropathy [20,21].
FIG4 is a 5-phosphatase involved in the dephosphorylation of
PtdIns(3,5)P2, a predicted substrate of MTMR2. Loss of Fig4 in
the mouse causes the plt (pale tremor) phenotype, characterized by
extensive neuronal vacuolization and degeneration and by a
peripheral neuropathy [20,22].
Yeast Fig4 is localized at the vacuolar membrane-the yeast
lysosomal compartment- and is required for both the
generation and turnover of PtdIns(3,5)P2 [23,24]. In addition
to the 5-phosphatase activity, yeast Fig4 appears to activate
Fab1, the kinase that produces PtdIns(3,5)P2 from PtdIns3P
[23,24]. Deletion of yeast Fig4 reduces rather than increases
PtdIns(3,5)P2 leading to defects in vacuole homeostasis and
function. A significant decrease of PtdIns(3,5)P2 was found also
in plt (Fig4-null) fibroblasts, suggesting conserved enzymatic
and cellular functions of Fig4 from yeast to mouse [20].
Moreover, the most common human mutation of FIG4 acts by
reducing its affinity for the PtdIns(3,5)P2 biosynthetic complex
[25].
Since FIG4 has a role in generation of PtdIns(3,5)P2 and
MTMR2 catalyzes its dephosphorylation, these two phospha-
tases might have opposite effects in the control of PtdIns(3,5)P2
homeostasis and their mutations might have compensatory
effects in vivo.T oe x p l o r et h er o l eo ft h eM T M R 2p h o s p h o l i p i d
phosphatase activity in vivo, we took advantage of the Fig4 and
Mtmr2-null mice and generated and characterized the Mtmr2/
Fig4 double null mutant. Here we provide strong evidence that
Mtmr2 and Fig4 functionally interact in both Schwann cells
and neurons, and reveal for the first time a role of Mtmr2 in
neurons in vivo. We also report that the imbalance of
PtdIns(3,5)P2 might be at the basis of myelin outfolding in the
nerve. Reduction of Fig4 by null heterozygosity and downreg-
ulation of PIKfyve both rescue Mtmr2-null myelin outfoldings in
vivo and in vitro.
Results
Generation of Mtmr2/Fig4-null mice
The generation and characterization of Mtmr2-null and Fig4-
null (plt) mice have been reported [17,20]. Mtmr2/Fig4 double null
mice and controls were analyzed in the F2 generation. At postnatal
day three (P3) Mtmr22/2Fig42/2 mice had reduced body size
and diluted pigmentation of the coat similar to the Mtmr2+/
+Fig42/2 mice in the same litter, and as reported for the plt
mouse [20]. Tremor and abnormal gait developed in the second
week after birth. Mtmr2+/+Fig42/2 mice show juvenile lethality
and die around 1 month of age. The viability of Mtmr22/2
Fig42/2 mice was lower than for Mtmr2+/+Fig42/2 littermates.
A reduced number of both Mtmr2+/2Fig42/2 and Mtmr22/2
Fig42/2 mice were present at P8, compared to the expected
Mendelian ratio (Table 1 and Table 2). The longest survival of the
double mutant was 20 days. The data indicate that loss of Mtmr2
reduces viability of Mtmr2+/+Fig42/2. We therefore hypothe-
sized that loss of Mtmr2 might provoke a worsening of the
Mtmr2+/+Fig42/2 neurodegeneration.
Mtmr2 loss exacerbates Fig4-null neurodegeneration
To explore this possibility, we performed semithin section
analysis of DRG ganglia, brain and spinal cord from Mtmr2+/
+Fig42/2 and Mtmr22/2Fig42/2 mice. DRG ganglia from
both Mtmr2+/+Fig42/2 and Mtmr22/2Fig42/2 mice at P3
were severely affected, exhibiting neuronal loss and massive
vacuolization (Figure 1A–1C). In the cerebellum of both Mtmr2+/
+Fig42/2 and Mtmr22/2Fig42/2 mice at P8 and at P20 we
observed a thickening of the molecular layer as compared to wild-
type, and cells with cytoplasmic vacuoles were present in the
granular layer. At P20, a consistent loss of Purkinjie and basket
cells was observed in both genotypes (Figures S1 and S2). These
cerebellar findings have not been previously reported in the plt
mouse.
In the cortex and brainstem of Mtmr22/2Fig42/2 mice at P3
we noted more cells with vacuoles and inclusions than in Mtmr2+/
+Fig42/2 mice, which were never been observed in wild-type
animals (Figure 1D–1I). In particular, in the brainstem of
Mtmr22/2Fig42/2 mice at P8 the number of neurons carrying
pathological abnormalities was significantly increased as compared
to Mtmr2+/+Fig42/2 mice (Figure 1J–1L). We also analyzed the
spinal cord of Mtmr2+/+Fig42/2 and Mtmr22/2Fig42/2 mice
at P3 and P8 (Figure 2A–2F). Vacuolated cells and cells with
inclusions were observed, as previously described for the plt
phenotype, which were not present in wild-type spinal cords
[20,26]. At P8, we observed a significant decrease in the number
Table 1. Number of mice with Mtmr2+/+Fig42/2, Mtmr2+/
2Fig4, and Mtmr22/2Fig42/2 genotypes scored at P8 on a
total of 608 mice.
MTMR2 FIG4 Predicted Observed P values
+/+ 2/2 38 34 0.28
+/22 /2 76 56 0.007
2/22 /2 38 10 ,0.0001
‘‘Predicted’’ refers to the number of expected mice among 608 mice born,
based on Mendelian ratios. ‘‘Observed’’ refers to the mice identified by
genotyping at P8. The number of mice decreases with loss of Mtmr2 on a Fig4-
null background. P values were calculated for a binomial distribution, using the
chi-square test.
doi:10.1371/journal.pgen.1002319.t001
Author Summary
Charcot-Marie-Tooth type 4B1 (CMT4B1) and Charcot-
Marie-Tooth type 4J (CMT4J) are severe autosomal
recessive demyelinating neuropathies with childhood
onset. We previously demonstrated that loss of the
phospholipid phosphatase MTMR2 causes CMT4B1 with
myelin outfoldings in human and mouse and that loss of
the phospholipid phosphatase FIG4 causes CMT4J and
neurodegeneration in the mouse. MTMR2 has a predicted
role in membrane trafficking, which is crucial for myelin
membrane biogenesis and homeostasis. However, the
biochemical activity of MTMR2 in vivo and the role of
MTMR2 in myelination still remain to be assessed. MTMR2
and FIG4 act on the same phospholipid substrate
PtdIns(3,5)P2, but with predicted opposite effects. We
generated a double Mtmr2/Fig4-null mouse which
showed that Mtmr2 and Fig4 interact in neurons and
Schwann cells to control phospholipid metabolism.
Moreover, Mtmr2-null myelin outfoldings are rescued by
Fig4 heterozygosity, suggesting that imbalance of
PtdIns(3,5)P2 is at the basis of the excessive myelin
growth and hypermyelination.
FIG4/MTMR2 Interaction in the Nervous System
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compared to Mtmr2+/+Fig42/2 mice (Figure 2H, 2I). These
findings demonstrate that loss of Mtmr2 exacerbates the Mtmr2+/
+Fig42/2 neurodegeneration.
This effect could be the consequence of loss of Mtmr2 in
neurons or in other cells, such as in astrocytes. For example, in the
plt mouse, a block of autophagy in astrocytes has been reported. In
plt mice at 1 week of age, the p62 autophagy marker was increased
in GFAP-positive astrocytes from brain regions severely affected at
later stages, suggesting that autophagy impairment contributes to
the pathogenesis [26]. Elevated p62 co-localized with LAMP2-
positive late endosomes/lysosomes (LE/LY) in astrocytes, showing
Table 2. The relative risk (RR) of lethality for the Mtmr2+/+Fig42/2, Mtmr2+/2Fig42/2, and Mtmr22/2Fig42/ genotypes.
Genotype 1 Genotype 2 RR (95%CI) Chi-square P values
Mtmr2+/+Fig42/2 Mtmr2+/2Fig42/2 2.5 (0.92, 6.80) 2.91 0.09
Mtmr2+/+Fig42/2 Mtmr22/2Fig42/2 7 (2.72, 18.03) 28.55 9610
28
Mtmr2+/2Fig42/2 Mtmr22/2Fig42/2 2.8 (1.84, 4.27) 21.42 4610
26
The relative risk analysis was performed on the 608 animals scored at P8, as also reported in Table 1.
doi:10.1371/journal.pgen.1002319.t002
Figure 1. Neurodegeneration in Mtmr2+/+Fig42/2 and Mtmr22/2Fig42/2 mice. Semithin section analysis of DRG ganglia, cortex and
brainstem of wild-type (A, D, G) and mutant mice (B, C, E, F, H, I). (B, C) DRG sensory neurons from Fig4-null and Mtmr2/Fig4 double null mice at P3 with
massive vacuolization. (F, I) More cells carrying inclusions and vacuoles were observed in Mtmr22/2Fig42/2 cortex (F) and brainstem (I) at P3 as
compared to Mtmr2+/+Fig42/2 mice (E, H).(K, L) Brainstem analysis at P8 showed increased number of pathological neurons in Mtmr22/2Fig42/2 (L)
as compared to Mtmr2+/+Fig42/2 mice (K) and quantification in (J), P=2.75610
26. A total of 10030, 10290, and 9620 neurons were counted and
analyzed in wild-type Mtmr2+/+Fig42/2, and Mtmr22/2Fig42/2 mice, respectively. All neurons scored were normal in wild-type, whereas 48.3% and
81.1% of neurons displayed pathological features in Mtmr2+/+Fig42/2, and Mtmr22/2Fig42/2, respectively. Arrows indicate inclusions; arrowheads
vacuoles. Three mice per genotype were analyzed. Bar is 35 mm in (A–C), 10 mm in (D–L).
doi:10.1371/journal.pgen.1002319.g001
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autophagosomes with LE/LY [26]. To determine whether loss of
Mtmr2 in astrocytes might further impair autophagy, we evaluated
p62 levels in total brain extracts from Mtmr2+/+Fig42/2 as
compared with Mtmr22/2Fig42/2 mice. Increased p62,
LAMP1 and GFAP expression levels were confirmed in
Mtmr2+/+Fig42/2 as compared to wild-type but no differences
were detected between Mtmr2+/+Fig42/2 and Mtmr22/
2Fig42/2 double null mice (Figure 3A). This finding indicates
that loss of Mtmr2 does not further impair the block in the
autophagic process in astrocytes of Fig4-null mice.
To further investigate the cell autonomy of the Mtmr2/Fig4
interaction, we established dissociated Schwann cell/DRG neuron
co-cultures from Mtmr2+/+Fig42/2 and Mtmr22/2Fig42/2
mice, in which mutant Schwann cells were replaced with
exogenous wild-type rat Schwann cells. Mtmr22/2Fig42/2
DRG neurons cultured with wild-type Schwann cells were
significantly more severely vacuolated (57.8%) as compared to
Mtmr2+/+Fig42/2 cultures (37.4%) (Figure 3B–3D9 and 3H).
This finding provides strong evidence that the loss of Mtmr2 in
neurons leads to the worsening of the Fig4-null neurodegeneration.
Like neurons, mouse primary fibroblasts (MFs) from plt mutants
display enlargement and vacuolization of the LAMP2-positive
LE/LY compartment [20,22]. To provide further evidence for
functional interaction between MTMR2 and FIG4, we established
MF cultures from Mtmr2+/+Fig42/2 and Mtmr22/2Fig42/2
mice. By LAMP1 staining and confocal microscopy, we observed
that the number of fibroblasts carrying enlarged LE/LY was
significantly increased in Mtmr22/2Fig42/2 double mutants as
compared to Mtmr2+/+Fig42/2 (Figure 4). This finding indicates
that Mtmr2 loss exacerbates Fig4-null vacuolar phenotype by
further impairment of the endo/lysosomal trafficking pathway.
Mtmr2 exacerbates Fig4-null hypomyelination in sciatic
nerve
The plt mouse phenotype is characterized by a peripheral
neuropathy. Loss of large diameter myelinated axons, hypomye-
lination (reduced myelin thickness), reduced amplitude of
compound motor action potential (cMAP) and slowing of the
nerve conduction velocity (NCV) have been reported in plt mouse
nerves at 6 weeks of age [20,22]. The extent of the NCV reduction
in plt mice and the presence of demyelinating features in CMT4J
patient biopsies such as onion bulbs suggested that FIG4 has also a
cell autonomous role in Schwann cells [22].
We investigated sciatic nerves from Mtmr2+/+Fig42/2 and
Mtmr22/2Fig42/2 mice. At P3 and P8, mutant sciatic nerves
showed a normal development. In both genotypes at P8, Schwann
cells often contained cytoplasmic inclusions and occasionally
Figure 2. Semithin section analysis of spinal cord from Mtmr2+/+Fig42/2 and Mtmr22/2Fig42/2 mice. At P3 (A–C) and P8 (D–F),
cytoplasmic inclusions and vacuolization, leading to extensive cell loss were observed in the spinal cord of Mtmr2+/+Fig42/2 and Mtmr22/2Fig42/2
mutant mice. By counting the number of cells in at least 15 sections of spinal cord per genotype (H, I), a significant decrease in the number of
motorneurons(H)andofcells(I)(permm
2)wasobservedatP8inMtmr22/2Fig42/2spinalcordsascomparedtoMtmr2+/+Fig42/2(andwild-type).In
(H) Mtmr2+/+Fig42/2 as compared to Mtmr22/2Fig42/2, P=0.04893; wild-type as compared to Mtmr22/2Fig42/2, P=0,02107; in (I), Mtmr2+/
+Fig42/2ascomparedtoMtmr22/2Fig42/2,P=0.0134245;wild-typeascomparedtoMtmr22/2Fig42/2,P=0.008836. (G)Electronmicroscopyofa
motorneuron showing cytoplasmic electrondense inclusion and vacuoles. Arrows indicate inclusions; arrowheads vacuoles. Bar is 10 mm in (A–F) and
1 mmi n( G ) .
doi:10.1371/journal.pgen.1002319.g002
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PLoS Genetics | www.plosgenetics.org 4 October 2011 | Volume 7 | Issue 10 | e1002319Figure 3. Mtmr2 loss in neurons exacerbates Fig4-null neurodegeneration. (A) Western blot analysis of brain extracts from wild-type,
Mtmr2+/+Fig42/2, and Mtmr22/2Fig42/2 mice at P20. P62, GFAP, and LAMP1 are increased in Mtmr2+/+Fig42/2 as compared to wild-type as
already reported for the plt mouse. No differences were detected between Mtmr2+/+Fig42/2 and Mtmr22/2Fig42/2, suggesting that loss of
FIG4/MTMR2 Interaction in the Nervous System
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nerves. At P20, the latest time point of survival of Mtmr2/Fig4
double null mice, Mtmr2+/+Fig42/2 sciatic nerves were
hypomyelinated (thin myelin sheath) with an increased g-ratio
(diameter of the axon divided by the diameter of the fiber) as
compared to wild-type nerves (Figure 5E). At this stage, sciatic
nerves from Mtmr22/2Fig42/2 double null mice were more
severely hypomyelinated than Mtmr2+/+Fig42/2 mice with a
higher g-ratio, demonstrating that Mtmr2 loss exacerbates the
neuropathy of Mtmr2+/+Fig42/2 mice (Figure 5E). The total
number of fibers and the axonal diameter distribution at P20 were
not significantly altered in mouse nerves of either genotype
(Figure 5F). These observations indicate that the hypomyelination
is not a developmental defect related to delayed axonal growth.
Hypomyelination may result from a defective axonal/Schwann
cell interaction due to the severe neuronal degeneration and/or
from the loss of FIG4 in Schwann cells. We thus cultured
dissociated DRG neurons from Mtmr22/2Fig42/2 and
Mtmr2+/+Fig42/2 mice, seeded with exogenous wild type rat
Schwann cells. Following induction of myelination by ascorbic
acid treatment, vacuolated DRG neurons from both Mtmr22/2
Fig42/2 and Mtmr2+/+Fig42/2 mouse embryos were able to
produce myelinated segments, although significantly fewer than
wild-type cultures. Moreover, DRG neurons from Mtmr22/2
Fig42/2 mice cultured with wild-type Schwann cells produced
significantly fewer myelinated segments than Mtmr2+/+Fig42/2
neurons seeded with wild-type Schwann cells (Figure 3E–3G and
quantification in panel I). This observation suggests that the
hypomyelination of Mtmr2+/+Fig42/2 nerves represents at least
in part the consequence of impaired Schwann cell-axonal
interaction.
Fig4 heterozygosity rescues Mtmr2-null myelin
outfoldings
To further investigate Mtmr2 and Fig4 interaction in the nerve,
we evaluated whether loss of Fig4 modifies the myelin outfolding
phenotype. Myelin outfoldings in Mtmr2-null mice arise around
the third to fourth week after birth, and the number of fibers
containing myelin outfoldings and loops progressively increases
with age (up to 6 months or even later). Since Mtmr22/2Fig42/2
double mutants die before 1 month of age, we compared sciatic and
peroneal nerves at 6 months of age from Mtmr22/2Fig4+/+ and
Mtmr22/2Fig4+/2 (Fig4 heterozygous) mice. Using semithin
section analysis, we measured the number of fibers carrying myelin
outfoldings in mutant sciatic and peroneal nerves normalized to the
total number of fibers. In Mtmr22/2Fig4+/2 nerves myelin
outfoldings were significantly reduced as compared to Mtmr22/2
Fig4+/+ mice(Figure 6A–6D). Sinceloss of Mtmr2inSchwann cells
isboth sufficientand necessarytoprovoke myelinoutfoldings,loss of
Fig4 in Schwann cells (rather than axons) is likely to account for the
rescue of the disease phenotype.
To further evaluate this finding, we established myelin-forming
Schwann cell/DRG neuron co-cultures from Mtmr22/2Fig4+/+
and Mtmr22/2Fig4+/2 mouse embryos at E13.5 (Figure 7A,
7B). By measuring the number of MBP positive fibers carrying
myelin outfoldings in the cultures, we confirmed that Mtmr2-null
myelin outfoldings were rescued by Fig4 heterozygosity
(Figure 7C).
Loss of Fig4 in plt fibroblasts leads to a significant decrease in
PtdIns(3,5)P2, whereas Mtmr2 loss should lead to an increase in
both PtdIns3P and PtdIns(3,5)P2 in vivo in the nerve [20]. Indeed,
by performing a sensitive in vitro mass assay on Mtmr2-null
Schwann cell/DRG neuron co-cultures, we found that in null cells
PtdIns5P is significantly reduced (up to 70%) as expected by the
loss of MTMR2 3-phosphatase activity on PtdIns(3,5)P2
(Figure 8A). We hypothesized that the observed rescue by Fig4
heterozygosity might be the consequence of a restored level of
PtdIns(3,5)P2 in Schwann cells. Heterozygosity of Fig4 might
decrease PIKfyve activity and therefore partially restore
PtdIns(3,5)P2 levels in Mtmr2-null cells.
To test this hypothesis, we downregulated either the activity or
expression of PIKfyve in Mtmr2-null co-cultures to rescue myelin
Mtmr2 does not further impair astrocytosis and the block in the autophagic process in astrocytes. (B–G) Dissociated DRG explants from wild-type (B,
B9, E), Mtmr2+/+Fig42/2 (C, C9, F), and Mtmr22/2Fig42/2 (D, D9, G) mice, in which mutant Schwann cells were replaced by exogenous wild-type rat
Schwann cells. (D, D9) More Mtmr22/2Fig42/2 neurons (n=303 neurons on 523 total neurons) are vacuolated as compared to Mtmr2+/+Fig42/2
neurons (C, C9; n=236 on 635 total neurons; P=7.56271610
28, 16 covers per genotype, and quantification in H). (G) Mtmr22/2Fig42/2 co-cultures
produced less myelinated MBP-positive segments after 7 days of ascorbic acid treatment (n=52 segments on 16 coverslips) as compared to Mtmr2+/
+Fig42/2 (F) (n=234 segments on 12 coverslips; P=1.9218610
25) and quantification in (I). Both Mtmr2+/+Fig42/2 and Mtmr22/2Fig42/2
explants are severely hypomyelinated as compared to wild-type (E) (n=6560 segments on 16 coverslips). Green is neurofilament (NF-L); red is myelin
basic protein (MBP), staining compact myelin. Arrowheads in (C, D, C9,D 9) indicate vacuoles within sensory neurons. Bar in (B–G) is 50 mm.
doi:10.1371/journal.pgen.1002319.g003
Figure 4. Enlarged late endosomal compartment in primary
fibroblasts from Mtmr2+/+Fig42/2 and Mtmr22/2Fig42/2 mu-
tant mice. (A–C) The number of fibroblasts carrying enlarged late
endosomal/lysosomal compartment (LAMP1 positive, green) is signif-
icantly increased in Mtmr22/2Fig42/2 (B) as compared to (A) Mtmr2+/
+Fig42/2. In red is phalloidin which stains actin filaments. Blue, DAPI.
The quantification in (D) was made by counting cells established from
three animals per genotype. n=526 on 17 coverslips for Mtmr2+/
+Fig42/2; n=583 cells on 20 coverslips for Mtmr22/2Fig42/2;
P=0.000079; confocal microscopy analysis. Asterisks mark cells carrying
enlarged late endosomal compartments. Bar in (A–C) is 25 mm.
doi:10.1371/journal.pgen.1002319.g004
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vectors (LV) carrying PIKfyve shRNA and scored the number of
myelinated MBP-positive fibers with myelin outfoldings. Titration
of the PIKfyve shRNA LV was previously performed to determine
the highest amount of virus which does not significantly affect
myelination (Figure S3A, S3B). We found that myelin outfoldings
were significantly rescued by downregulating PIKfyve expression
(Figure 7D–7F90 and 7I). We also treated Mtmr2-null cultures with
a specific pharmacological inhibitor of PIKfyve, YM201636 [27–
29]. Titration of the compound was performed to determine the
maximum amount of YM201636 that does not inhibit myelination
(Figure S3A, S3B). Seventy nM final concentration of YM201636
was freshly added to the culture media every other day together
with ascorbic acid to achieve full myelination. A significant
reduction of myelin outfoldings was confirmed in Mtmr2-null
cultures treated with YM201636 as compared with DMSO alone
(Figure 7G, 7H, 7J). The data suggest that reduction of the level of
PtdIns(3,5)P2, either by heterozygosity for Fig4 or by inhibition of
PIKfyve, corrects the myelin abnormality of Mtmr2-null cells This
result predicts that the level of PtdIns(3,5)P2 may be elevated in
Mtmr2-null cells.
Phospholipid analysis in mouse fibroblasts
To correlate MTMR2 and FIG4 functional interaction with
changes in PI levels, we measured PtdIns3P and PtdIns(3,5)P2
levels from wild-type; Mtmr22/2Fig4+/+; Mtmr2+/+Fig42/2;
Mtmr22/2Fig42/2, and Mtmr22/2Fig4+/2 fibroblasts by
metabolic labeling and HPLC analysis (Figure 8). PtdIns3P levels
were similar in all the genotypes analyzed (data not shown). In
mammalian cells, PtdIns3P generation and turnover are controlled
by multiple redundant pathways, so that ablation of one particular
enzyme such as myotubularins does not necessarily result in an
imbalance of PtdIns3P, as already reported [9,30,31].
On the otherhand,we found that lossof Fig4 inFig4-null fibroblasts
results in a significant decrease of PtdIns(3,5)P2as compared to control
cells, thus confirming previous findings [20] (Figure 8B). As also
suggested by the in vitro mass assay performed on Mtmr2-null myelin-
forming co-cultures (Figure 8A), loss of Mtmr2 in Mtmr2-null
fibroblasts leads to a significant increase in PtdIns(3,5)P2 level,
consistently with the 3-phosphatase activity of MTMR2 (Figure 8C).
Moreover, PtdIns(3,5)P2 was equally reduced in Fig42/2 and in
Mtmr22/2Fig42/2 cells (Figure 8B), possibly because the
PtdIns(3,5)P2 substrate is already severely affected by loss of Fig4,
and Mtmr2 acts downstream of Fig4 in the control of this lipid level.
To support the hypothesis that myelin outfoldings in
Mtmr22/2Fig4+/2 co-cultures were rescued because of
restored PtdIns(3,5)P2 levels, we also measured PtdIns(3,5)P2
in Mtmr22/2Fig4+/+ and Mtmr22/2Fig4+/2 fibroblasts.
However, PtdIns(3,5)P2 did not differ in Mtmr22/2Fig4+/+
and Mtmr22/2Fig4+/2 fibroblasts (Figure 8C). Small changes
in PtdIns(3,5)P2 levels due to loss of 50% of phosphatase
expression may be below the level of detection of this method.
Overall, these findings indicate that Mtmr2 and Fig4 control
PtdIns(3,5)P2 with opposite effects. If Fig4 is totally absent and
PtdIns(3,5)P2 is low, the absence of Mtmr2 which dephosphory-
lates PtdIns(3,5)P2 has no influence. On the other hand, when
PtdIns(3,5)P2 is high due to loss of Mtmr2, a partial reduction in
PIKfyve activity due to heterozygosity of Fig4 might lead to
PtdIns(3,5)P2 rebalance and rescue of myelin outfoldings.
Finally, we tested for interaction between phosphatases using a
pull-down assay. GST-MTMR2 was not able to pull-down Fig4
Figure 5. Hypomyelination in Mtmr2+/+Fig42/2 and Mtmr22/
2Fig42/2 sciatic nerves. (A–C and E) At P20, the g-ratio (the ratio
between axonal diameter and the fiber diameter-axon plus myelin) in
Mtmr2+/+Fig42/2 sciatic nerves (0.67460.0014) is increased as
compared to wild-type (0.640860.0013; P=8.0253610
263), suggesting
the presence of hypomyelination, a reduction in myelin thickness. The
g-ratio of Mtmr22/2Fig42/2 (0.688560.0015) sciatic nerves is further
increased as compared to Mtmr2+/+Fig42/2 nerves (P=2.870336
10
212), suggesting that loss of Mtmr2 exacerbates hypomyelination of
Fig4-null. (D) Electron microscopy of a Mtmr22/2Fig42/2 nerve,
showing myelin debris and axonal degeneration. (F) The axon diameter
distributionisnormalinbothMtmr22/2Fig42/2andMtmr2+/+Fig42/2
as compared to wild-type, thus excluding loss of axons. In (E, F) axon
diameter is in mm scale. From 4 to 5 animals per genotype were analyzed.
n=3450 fibers for wild-type; n=2650 fibers for Mtmr2+/+Fig42/2,a n d
n=2746fibers for Mtmr22/2Fig42/2,t - t e s ta n a l y s i s .B a ri s2mmin(A –C )
and 1 mmi n( D ) .
doi:10.1371/journal.pgen.1002319.g005
Figure 6. Fig4 heterozygosity rescues Mtmr2-null myelin out-
foldings. (A, B) Asterisks indicate myelinated fibers from sciatic nerve
carrying myelin outfoldings. (C) Quantification of fibers carrying myelin
outfoldings in sciatic nerves from Mtmr22/2Fig4+/+ and Mtmr22/
2Fig4+/2 mice and (D) in peroneal nerves, using semithin section
analysis. Four animals per genotype were analyzed. The entire nerve
section was reconstructed and the number of fibers carrying myelin
outfoldings divided for the total number of fibers was counted.
P=0.0097 in (C) and P=0.0086 in (D). Bar is 10 mm in (A, B).
doi:10.1371/journal.pgen.1002319.g006
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functional interaction between MTMR2 and FIG4 demonstrated
here is not mediated by physical interaction between the two
proteins (Figure S3C–S3E).
Mammalian MTMR2 converts PtdIns(3,5)P2 and PtdIns3P
in yeast
The mutant yeast strain fig4D displays enlarged vacuoles caused
by reduced PtdIns(3,5)P2, which in yeast controls the homeostasis
of the vacuole (the lysosomal compartment). To further test
Mtmr2 function, and further test functional interactions between
Mtmr2 and Fig4, we transformed FLAG-MTMR2 in the mutant
yeast strain fig4D. Overexpression of wild-type MTMR2 in fig4D
caused a further enlargement of the vacuolar compartment and
defects in vacuole fission whereas the catalytically inactive mutant
FLAG-MTMR2C417S did not cause these changes (Figure 9). To
determine the substrates and products of mammalian MTMR2 in
yeast, we measured phosphorylated phosphoinositide lipid levels
from cells expressing FLAG-MTMR2 as compared to the vector
alone. To enhance the sensitivity of the assay, we subjected the
Figure 7. A rebalance of PtdIns(3,5)P2 rescues Mtmr2-null myelin outfoldings in vitro. (A, B) Heterozygosity of Fig4 in Mtmr2-null explants
rescues myelin outfoldings. (C) The number of MBP positive segments carrying myelin outfoldings on the total of MBP segments on random fields
was assessed. Mtmr22/2Fig4+/+ n=383 fibers; Mtmr22/2Fig4+/2 n=405 fibers, on at least 5 covers per genotype; P=1.97554610
25. (D) Decrease
of PIKfyve expression on lysates from myelin-forming Schwann cells/DRG explants transduced with PIKfyve shRNA lentiviral vector (LV), as compared
to a scramble sequence. (E–F90 and I) Myelin outfoldings are rescued in Mtmr2-null transduced by PIKfyve shRNA LV as compared to cultures
transduced with a scramble sequence (PIKfyve, n=423 and scramble, n=484; P=6610
26). (G, H, and J) Myelin outfoldings are rescued in Mtmr2-null
treated with 70 nM of YM201636 PIKfyve inhibitor as compared to cultures treated with DMSO (YM201636 n=913; DMSO, n=857; P=6.5610
27). Bar
is 20 mm in (A, B, E–F0, and G, H). Green is neurofilament (NF-L); red is myelin basic protein (MBP), staining compact myelin. Arrowheads indicate
myelin outfoldings.
doi:10.1371/journal.pgen.1002319.g007
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transient increase in PtdIns(3,5)P2 levels (green line) and
concomitant decrease in PtdIns3P (blue line) (Figure 10, 5 min
time point). If MTMR2 acts on PtdIns(3,5)P2, then there should be
a decrease in PtdIns(3,5)P2 and a corresponding increase in
PtdIns5P. Moreover, if MTMR2 acts on PtdIns3P there will be a
decrease in that lipid as well. Each of these changes was observed
(Figure 10, solid lines and Table S1). These findings demonstrate
that MTMR2 acts on both PtdIns(3,5)P2 and PtdIns3P in yeast,
and strongly suggest that MTMR2 acts on both of these substrates
in mammalian cells as well. These observations support the
hypothesis that MTMR2 and FIG4 coordinately regulate the
PtdIns3P-PtdIns(3,5)P2 pathway in vivo.
Discussion
The MTMR2 3-phosphatase activity toward PtdIns3P and
PtdIns(3,5)P2 has been demonstrated by a number of studies
using recombinant MTMR2 in vitro as well as conventional cell
lines overexpressing MTMR2 [10–16]. Overexpressed
MTMR2 has been co-localized with Rab7 in A431 cells at
the level of late endosome/lysosomes, where PtdIns(3,5)P2 is
generated [16]. Interestingly, another phospholipid phospha-
tase, FIG4/SAC3, is involved in both the dephosphorylation
and the production of PtdIns(3,5)P2 and is mutated in
autosomal recessive demyelinating CMT4J neuropathy [20].
Loss of Fig4 in mouse provokes the plt phenotype characterized
by massive neurodegeneration and peripheral neuropathy. In
Fig4-null fibroblasts a decrease in PtdIns(3,5)P2 has been
demonstrated, suggesting that Fig4 promotes PtdIns(3,5)P2
production by PIKfyve activation or stabilization [20]. Thus,
MTMR2 and FIG4 could have opposite effects in the control of
PtdIns(3,5)P2.
To explore the biological role of MTMR2 phosphatase activity
in the nerve in vivo, we generated a Mtmr2/Fig4 double null
mutant. Analysis of these mice provides evidence that Mtmr2 and
Fig4 functionally interact in neurons, fibroblasts, and Schwann
cells. Loss of Mtmr2 reduces the viability and exacerbates the
neurodegeneration of Fig4-null mice.
These results also provide the first evidence for a role for
MTMR2 in neurons in vivo, consistent with the marked axonal loss
in CMT4B1 patients [32]. Although conditional ablation of
Mtmr2 in motorneurons in mice did not reveal signs of axonal
degeneration or neuronopathy, a cell autonomous role of Mtmr2
Figure 8. PI measurements from primary fibroblasts and Schwann cell/DRG co-cultures. (A)PtdIns5Pwasmeasuredbyinvitromassassayin
DRG co-cultures from Mtmr2+/2 or Mtmr22/2 knock-out mice as described in Materials and Methods. Data are expressed as mean 6 s.e.m. (n=3 pools
ofatleast 6 differentexplantsper genotype). *P,0,05.(B–D) Fibroblasts fromwild-type, Mtmr2+/+Fig42/2, Mtmr22/2Fig4+/+, Mtmr22/2Fig42/2,a n d
Mtmr22/2Fig4+/2 mice were labeled for 16 h with [
32P]orthophosphate. Lipids were extracted, deacylated and analyzed by HPLC. PtdIns(3,5)P2 is
expressed as percent of PtdIns(4,5)P2. Data are expressed as mean 6 s.e.m. (n=3). No differences in PtdIns3P levels were demonstrated between the
different genotypes analyzed (not shown). (B) PtdIns(3,5)P2 levels were significantly reduced in Mtmr2+/+Fig42/2 cells as compared to wild-type, thus
also confirming previous findings [20], whereas Mtmr2+/+Fig42/2 and Mtmr22/2Fig42/2 cells showed similar levels of this lipid (P=0.0071 between
wild-type and Fig42/2; P=0.0044, between wild-type and double null cells). (C) Loss ofMtmr2 in Mtmr22/2Fig4+/+ cells provoked a significant increase
of PtdIns(3,5)P2 (P=0.0096), whereas no differences were detected between Mtmr22/2Fig4+/+ and Mtmr22/2Fig4+/2 cells, possibly because
heterozygous deletionof Fig4 leads to small PIchanges hardly detectable using this method. (D) Comparison betweenthe two independent experiments
showed in (B) and (C), where each value was proportioned to the wild-type belonging to the same experiment and wild-type values were arbitrarily
converted to 1 (P=0.0055 when comparing Mtmr22/2Fig42/2 and Mtmr22/2Fig4+/+ cells).
doi:10.1371/journal.pgen.1002319.g008
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dependent and not easily reproduced in mice [18]. Interestingly, a
role for MTMR2 in neurons in vitro has been recently reported
suggesting that Mtmr2 is localized to excitatory synapses of central
neurons via direct interaction with the PSD-95 scaffolding protein
[33]. Knockdown of Mtmr2 in cultured neurons markedly
Figure 9. MTMR2 and FIG4 interaction in yeast. Expression of human FLAG-MTMR2 in the mutant yeast strain fig4D, caused enlarged vacuoles
and a defect in vacuole fission. Wild-type and fig4D expressing pVT102U (vector), pVT102U-MTMR2 or pVT102U-MTMR2-C417S, were grown to mid-
log phase and the vacuole membrane was labeled with SynaptoRed C2. Arrow indicates an example of a bud vacuole that has not properly separated
from the mother vacuole. Scale bar, 6 mm.
doi:10.1371/journal.pgen.1002319.g009
Figure 10. MTMR2 3-phosphatase activity in yeast. Mouse MTMR2 has 3- phosphatase activity in vivo and converts PtdIns(3,5)P2 and PtdIns3P
to PtdIns5P and phosphatidylinositol, respectively. Expression of MTMR2 in yeast causes a decrease in PtdIns3P and PtdIns(3,5)P2 as well as an
increase in PtdIns5P. Mouse MTMR2 cDNA was subcloned into a yeast expression vector, pVT102U (vector) to express MTMR2 from the ADH
promoter, pVT102U-MTMR2. Yeast expressing MTMR2 or with vector alone were labeled with
3H-inositol for 18 h. Cells were exposed to 0.9 M NaCl
for the times indicated, Lipids were extracted, deacylated, and the corresponding glycerol-inositol phosphates were quantitated by high-pressure
liquid chromatography, reported as the percent of total [3H]phosphatidylinositol extracted. Two independent experiments are shown.
doi:10.1371/journal.pgen.1002319.g010
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proposed that the MTMR2/PSD95 complex contributes to the
maintenance of excitatory synapses by inhibiting excessive
endosome formation and destructive endosomal traffic to
lysosomes.
Here, we assessed MTMR2 and FIG4 interaction in yeast and
found that overexpression of MTMR2 reduces both PtdIns3P and
PtdIns(3,5)P2 leading to an increase in vacuole size in the fig4D
mutant. These findings support the in vivo role of MTMR2 as a 3-
phosphatase that acts on both PtdIns3P and PtdIns(3,5)P2.
Fig4 heterozygosity rescues myelin outfoldings due to Mtmr2
deficiency both in vivo and in vitro, thus providing evidence of the
Fig4 and Mtmr2 interaction in Schwann cells as well as neurons.
Loss of Mtmr2 specifically in Schwann cells provokes myelin
outfoldings. The presence of cytoplasmic inclusions in Schwann
cells and the reduced NCV in the Fig4-null mouse, and the typical
demyelinating features (onion bulbs) of CMT4J patients, all
strongly support a Schwann cell autonomous role for Fig4. But
how does loss of Fig4 in Schwann cells rescue Mtmr2-null myelin
outfoldings? We hypothesized that a 50% reduction of Fig4 might
be sufficient to rebalance the PtdIns(3,5)P2 elevation in Mtmr2-null
cells (Figure 11), thus reducing myelin outfoldings. MTMR2 loss
should lead to an increase of both PtdIns3P and PtdIns(3,5)P2,
whereas FIG4 loss reduces PtdIns(3,5)P2 levels. In agreement with
this model, we observed that downregulation of PIKfyve
expression or inhibition of its activity in Mtmr2-null co-cultures
reduced myelin outfoldings, as also observed with Fig4 heterozy-
gosity (Figure 11). Our results therefore suggest that imbalance of
PtdIns(3,5)P2 is at the basis of altered longitudinal myelin growth
and formation of myelin outfoldings. The observed rescue of
myelin outfoldings is likely mediated by restored PtdIns(3,5)P2
rather than PtdIns5P. PtdIns5P may be produced via dephosphor-
ylation of PtdIns(3,5)P2 by MTMRs, and can also be generated, at
least in vitro, by PIKfyve acting on phosphatidylinositol [34].
Therefore, Fig4 heterozygosity in Mtmr2-null cells would lead to a
further reduction in PtdIns5P rather than restoration, as for
PtdIns(3,5)P2.
PtdIns(3,5)P2 is thought to be localized to EE and the limiting
membranes of LE/LY, although it cannot be excluded that this
lipid might also be generated at other membranes. The lack of
specific probes to detect PtdIns(3,5)P2 prevents the definition of
other membrane localization [35,36]. Our studies raise the
question of how dys-regulation of PtdIns(3,5)P2 leads to aberrant
longitudinal myelin growth. Excessive longitudinal myelin growth
and myelin outfoldings might arise as a consequence of reduced
endocytosis/recycling and degradation or as a consequence of
increased exocytosis. One can speculate that increased
PtdIns(3,5)P2 due to loss of MTMR2 might favor exocytosis from
Figure 11. Model of MTMR2 and FIG4 phosphatase activities in the control of PtdIns3P- PtdIns(3,5)P2 metabolism. In red, altered
levels of PIs due to loss of MTMR2 and/or FIG4 are depicted. In blue, rebalanced levels of PtdIns(3,5)P2 in Mtmr2-null cells upon Fig4 heterozygosity
and downregulation of either PIKfyve expression or inhibition of its activity are shown.
doi:10.1371/journal.pgen.1002319.g011
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mechanism, which has been recently suggested to occur in
oligodendrocytes [37], accounts for the assembly of myelin
components during the active phase of myelination. In myelin
outfoldings, myelin thickness is normal, so a more subtle
mechanism of regulation would be involved. Increased
PtdIns(3,5)P2 might alter autophagy dynamics. However, we did
not observe any change on LC3II/I ratio and/or p62 levels in
Mtmr2-null nerves or in myelin-forming DRG co-cultures
(unpublished results).
Alternatively, MTMR2 may favor endocytosis and counteract
exocytosis during later stages of myelin biogenesis. The myelin
outfoldings may thus arise as a consequence of the loss of negative
control on the amount of membrane produced during myelina-
tion. Another alternative is that MTMR2 might control
endocytosis of specific transmembrane proteins linking Schwann
cell plasma membrane to the axonal plasma membrane, which
then act as signaling molecules to control longitudinal myelin
growth. Note that myelin outfoldings often contain axoplasm and
axons branches at paranodal regions thus following myelin
membrane outgrowth [17]. Along these lines, enhanced surface
localization of putative adhesion molecules due to loss of Mtmr2-
mediated endocytosis might result in the loss of control of myelin
elongation and thus in myelin outfoldings. Other members of the
MTMR family seem to possess similar biological functions.
MTMR4 was recently demonstrated to regulate the sorting of
endosomal cargos into recycling endosomes [38]. In C. elegans,
MTM6 and MTM9 were found to be involved in endocytosis [39]
whereas Drosophila Mtm (homologous to catalytically active
MTM1, MTMR1, and MTMR2) regulates both actin-based
plasma membrane morphogenesis and the endosomal influx
toward the endo-lysosomal axis [40]. Whether and how MTMR2
might regulate endocytosis in Schwann cells during postnatal
development remains to be assessed.
Materials and Methods
Ethics statement
All experiments involving animals were performed in accor-
dance with Italian national regulations and covered by experi-
mental protocols reviewed by local Institutional Animal Care and
Use Committees.
Mice
Mtmr2-null mice were backcrossed for at least 5 generations to
strain C57BL/6N.
Fig4+/2 heterozygous mice were maintained on the recombi-
nant inbred line CB.plt derived predominantly from strains
CAST/Ei and C57BL/6J (25%) [25].
Heterozygous Fig4+/2 males were crossed with Mtmr2-null
females to obtain Mtmr2+/2Fig4+/2 double heterozygous mice.
Double heterozygotes were crossed to generate Mtmr22/2Fig42/2
double null mice as well as Mtmr22/2Fig4+/2 mice for analysis.
Genotyping was performed as described [17,20].
Morphological analysis
Semithin morphological analysis was performed as described
previously [41]. For morphometric analysis in brainstem at P8,
neuronal damage was evaluated in the facial nucleus at the level of
the upper medulla oblongata (Bregma 25.88). For each experimen-
tal sample, microscopic images (130 um690 um, nine images per
slide, three slides for each brain) were taken with a digital camera
and processed by Adobe Photoshop 7.0 software. To be counted, a
cell (diameter .20 mm) had to be located in the facial nucleus and
100–150 cells were scored per section. Cells with abnormal
cytoplasm vacuolization were scored as pathological. The average
percentage of normal and damaged neurons for each sample was
considered for each experimental group to represent the neuronal
density.Countswereperformedindoubleblindby2investigatorson
slides with a number-code system, and results were analyzed.
The number of motorneurons and of total cells in spinal cord
was assessed by performing at least 15 sections for each spinal cord
from three animals per genotype as before and by counting the
number of cells per area-cell density (mm
2).
The proportion of fibers carrying myelin outfoldings in Mtmr2-
null nerves as compared to Mtmr2-null mice with Fig4+/2
heterozygosity was determined by measuring the number of fibers
carrying myelin outfoldings normalized to the total number of
axons per section (the entire nerve section was reconstructed).
Ultrathin morphological analysis was conducted as reported
previously [41]. For morphological analysis, three to five animals
were evaluated at each time point in most cases.
Primary mouse fibroblast (MF) culture
MFs were established at P3 from tails and legs chopped in pieces
and incubated after PBS washing with RPMI medium and 1 mL
Collagenase Type II (Stock=2000 U/mL in 16PBS, Worthing-
ton, LS004204) overnight at 37uC. The next day, cells were plated
in RPMI-1640 with 15% FBS/16 L-Glutamine/16 Pen/Strep.
Cells were subjected to only two-three passages to allow maximum
efficiency of metabolic labelling for PI measurement.
Phospholipid analysis
Fibroblasts were labeled for 16 h in phosphate free DMEM
(Invitrogen) containing 200 mCi/ml [
32P]orthophosphate (Perkin
Elmer). Lipids were extracted, separated on Silica gel G60 plates
and analyzed by HPLC as described previously [42].
PtdIns5P was quantified by mass assay as described [43]. Briefly
total lipids were extracted from duplicate or triplicate plates of
DRG co-cultures from Mtmr2+/2 or Mtmr22/2 knock-out mice
and separated on Silica gel G60 plate. Monophosphorylated PIs
were scraped, eluted from silica and assessed for PtdIns(4,5)P2
formation in vitro using the recombinant specific PIP4KIIalpha and
[gamma-
32P] ATP.
Antibodies
For western blot analysis and immunohistochemistry the
following antibodies were used: rat anti-LAMP1 (Iowa Hybridoma
bank), Guinea pig anti-P62 (Progen), rabbit anti-GFAP (Sigma),
rabbit anti-MAG (kindly provided by Dr. J. Salzer), rat anti-MBP
(kindly provided by Dr. V. Lee), mouse anti-MBP (Covance),
rabbit anti-NF-L (Chemicon), mouse anti-tubulin (Sigma), and
mouse anti-FIG4 (NeuroMab).
Schwann cell/DRG neuron co-cultures
Myelin-forming Schwann cell/DRG neuron co-cultures were
established from E13.5 mouse embryos as previously described
[19,44]. Myelination was induced by treatment for 15 days with
ascorbic acid (final concentration, 50 mg/ml) (Sigma-Aldrich).
Dissociated Schwann cell/DRG neuron co-cultures were estab-
lished as described but DRGs were first incubated with trypsin
(0.25%) for 45 min at 37uC. Cells were also mechanically
dissociated and then plated at a concentration of one to two
DRGs per glass coverslip. Isolated rat Schwann cells were
prepared as reported previously and cultured using DMEM with
10% of fetal calf serum, 2 ng/ml recombinant human neuregu-
lin1-b1 (R&D Systems), and 2 mM forskolin (Calbiochem).
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compound starting from 800 nM until 30 nM was performed on
co-cultures to select the maximum amount of coumpound which
did not affect myelination. As already described [27,28], 400 or
800 nM of compound provoked extensive cell vacuolization after
overnight incubation. YM201636 was provided to co-cultures at
70 nM every other day together with ascorbic acid for 13 days to
achieve full myelination.
Immunohistochemistry
Schwann cell/DRG neuron co-cultures were fixed for 15 min in
4% paraformaldehyde, permeabilized for 5 min in ice-cold
methanol at 220uC, blocked for 20 min with 10% normal goat
serum (Dako), 1% bovine serum albumin (BSA) (Sigma-Aldrich),
and then incubated with primary antibody for 1 h. After extensive
washing, the coverslips where incubated with the secondary
antibody for 30 min, washed, and mounted. For double
immunostaining with anti-NF-L and anti- MBP antibody, the
coverslips were blocked with 1% BSA, 10% NGS for 20 min on
ice, and primary antibodies were incubated overnight at 4uC.
For LAMP1 staining, fibroblasts were permeabilized using 0.1%
saponin after fixation. For immunolabeling, secondary antibodies
included fluorescein-conjugated (FITC) and rhodamine (tetra-
methylrhodamine isothiocyanate) (Jackson ImmunoResearch).
Coverslips were analyzed using TCS SP5 laser-scanning confocal
(Leica) or Olympus BX (Olympus Optical) fluorescent microscope,
and Zeiss Axiovert S100 TV2 with Hamamatsu OrcaII-ER.
Analysis of myelination
To quantify the amount of myelination, the number of MBP
positive segments in each explant/coverslip was assessed. As
myelination is also a function of the amount of neurites/axons and
of the Schwann cell number in the culture, the network of NF-L
positive filaments and the number of Schwann cells (DAPI) were
also evaluated in each explant. To quantify MBP-positive fibers
displaying myelin outfoldings, at least 200 MBP-positive myelin-
ated fibers per explant/coverslip were evaluated, in at least ten
different explants/coverslip. The percentage of MBP-positive
fibers showing myelin outfoldings among the total number of
MBP-positive fibers was counted.
Analysis of fibroblasts with enlarged late endosome/
lysosomes
Fibroblasts were stained using LAMP1 antibody and images
were acquired using a confocal microscope. Images were then
processed using the Image J software and those cells displaying
almost all LAMP1 positive endosomes bigger than 1.67 mm (only
occasionally observed in wild-type cells) were considered as
carrying enlarged late endosome/lysosomes.
Imaging and statistical analysis
Micrographs were acquired using a digital camera (Leica F300),
and figures were prepared using Adobe Photoshop, version 7.0
and 8.0 (Adobe Systems). Statistical analysis was performed using
the Student t test; two tails, unequal variants, and alpha=0.005
were used. Error bars in the graphs represent SEM.
Lentiviral vector (LV) preparation
To downregulate PIKfyve expression, a shRNA cloned into
pLKO.1 LV (human U6 promoter) without a GFP reporter was
used (clone ID TRCN0000150081). Non-concentrated LVs were
used for RNA interference. The transfer constructs were transfected
into 293FT cells together with packaging plasmids D8.9 and
pCMV-VSGV using Lipofectamine 2000 (Invitrogen). As control, a
vector encoding a shRNA to a nonspecific sequence (luciferase) was
used. Viral supernatants were collected 48 h after transfection,
centrifuged at 3000 rpm for 15 min, and frozen at 280uC.
To check for PIKfyve depletion, freshly plated rat Schwann
cells (10
6 cells per 100-mm plate) were incubated with the LVs
in DMEM, 10% FBS, and 2 mM L-glutamine plus forskolin
and rhNRG-1 (EGF domain, R&D). Cells were expanded for
an additional week and maintained in MEM, 10% FBS, 2 mM
L-glutamine and 2 mM forskolin before use. A western blot
using a anti-PIKfyve antibody (Santa Cruz) was performed.
Using non-concentrated LV, transduction of Schwann cell/
DRG neuron co-cultures was performed 4–5 days after
dissection by incubating the cells with LVs overnight. Cells
were then supplemented with C-media, and myelination was
induced after 2 days.
Glutathione S-transferase–binding assays
Glutathione S-transferase (GST) fusion proteins were expressed
in Escherichia coli BL21 cells and purified directly from bacterial
extract on glutathione-Sepharose 4 Fast Flow beads. Rat isolated
Schwann cells and mouse brains were homogenated, and protein
lysates were prepared using a binding buffer with 1%NP-40,
50 mM Tris buffer, pH 7.4, 10% glycerol, 100 mM NaCl,
10 mM NaF, 1 mM Na-vanadate. Equal amounts of protein
lysates were incubated for 4 h at 4uC with immobilized GST
fusion proteins and GST as control. After three washes with a
buffer containing 0.5% NP-40, the pellets were dissolved in SDS
sample buffer and analyzed by SDSPAGE and immunoblotting.
To show the relative amount of GST fusion proteins used, beads
were dissolved in SDS sample buffer and analyzed by SDS-PAGE,
and the gel was stained with Coomassie.
Yeast analysis and phospholipid measurement in yeast
Yeast cells were labeled with SynaptoRed C2 (Biotium, Inc.,
CA). 0.1 units of cells (at 600 nm) were collected and resuspended
in 250 ml fresh media. 6 ml of SynaptoRed C2 (10 mg/ml dissolved
in dimethyl sulfoxide) was added to the cells and incubated at
24uC for 1 hour. Cells were then washed 2 times with fresh media
and chased for 2.5 hours. Fluorescence and differential interfer-
ence contrast (DIC) images were generated using a DeltaVision
RT Microscope System (Applied Precision, WA). Images were
processed using Softworx and Adobe Photoshop.
Measurement of phosphoinositide levels were performed as
described previously [45]. Cells were grown in selective media to
mid-log phase, harvested, washed, and resuspended in synthetic
media lacking inositol. 1–4610
6 cells were inoculated into 5 ml of
media lacking inositol containing 5 mCi of myo-[2-
3H]-inositol.
Cells were labeled for 18 h at 24uC, harvested by centrifugation,
washed, and resuspended in 100 ml of inositol-free media. For
hyperosmotic shock, an equal volume of 1.8 M NaCl was added to
cells (for a final concentration of 0.9 M NaCl) and the resulting
suspension was incubated at 24uC for the times indicated. 800 ml
of ice cold 4.5% perchloric acid [46] was added to the cells. Cells
were lysed in the presence of 0.5-mm zirconia beads (Biospec,
Bartlesville, OK) on a Beadbeater (Biospec) for three cycles of
2 min at room temperature followed by 2 min on ice. Cell extracts
were centrifuged at 14,000 rpm for 10 min at 4uC. Precipitates
were washed with 1 ml of 100 mM EDTA, centrifuged
14,000 rpm for 10 min at 4uC, and resuspended in 50 mlo f
sterile distilled deionized water.
Lipids were deacylated by treatment with methylamine
[47].1 ml methylamine reagent (10.7% methylamine, 45.7%
methanol, 11.4% n-butanol) was added to each sample and
FIG4/MTMR2 Interaction in the Nervous System
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the pellets were resuspended in 300 ml of sterile water, centrifuged
at 14,000 rpm for 2 min and the supernatants were transferred to
new Eppendorf tubes. 300 ml of butanol/ethyl ether/formic acid
ethyl ester (20:4:1) was added to each. The samples were vortexed
and centrifuged at 14,000 rpm for 2 min. The aqueous phase
(bottom layer) was transferred to new tubes and the extraction was
repeated. At the end of the second extraction the aqueous phase
was dried in a SpeedVac. Samples were resuspended in 20 mlo f
sterile water and 15 ml of each was analyzed by HPLC using an
anion exchange, PartisphereSAX (Whatman), column. The
column was developed with a gradient of 1 M (NH4)2HPO4,
pH 3.8 (pH adjusted with phosphoric acid): 0% for 5 min, 1–2%
over 15 min, 2% for 80 min, 2–10% over 20 min, 10% for
65 min, 10–80% over 40 min, 80% for 20 min and finally 80-0%;
flow rate, 1.0 ml/min [48]. The value of each glycerol-inositol
corresponding to PtdIns3P, PtdIns4P, PtdIns5P, PtdIns(3,5)P2, and
PtdIns(4,5)P2 is reported as percent of total phosphoinositol, to
normalize number of cells and incorporation of [
3H] inositol.
Supporting Information
Figure S1 Semithin section analysis of the cerebellum from
Mtmr2+/+Fig42/2 and Mtmr22/2Fig42/2 mice at P8. A
disorganization of both the molecular and granular layer was
observed in the cerebellum of Mtmr2+/+Fig42/2 and
Mtmr22/2Fig42/2 mice. Middle panels show loss of Purkinjie
and basket cells which are not aligned at the border of the
granular layer. Inset is showing a cell carrying vacuoles in the
granular layer. Bar is 80 mmi n( A – C ) ;5 0mmi n( A 9–C9); 80 mm
in (A0)a n d5 0mmi n( B 0,C 0).
(TIF)
Figure S2 Semithin section analysis of the cerebellum from
Mtmr2+/+Fig42/2 and Mtmr22/2Fig42/2 mice at P20. The
loss of Purkinjie and basket cells is even more evident at P20 at the
border of the granular layer. More vacuolated cells are present in
the granular layer. Arrows indicate vacuolated cells. Bar is 80 mm
in (A–C) and 50 mmi n( A 9–C9).
(TIF)
Figure S3 (A) Example of shRNA PIKfyve lentiviral vector
titration to choose the highest amount of virus that did not
significantly inhibit myelination nor affect the quality of myelina-
tion. (B) Western blot analysis of lysates from Mtmr2-null co-
cultures transduced with the selected PIKfyve shRNA (12.5%) and
scramble, and treated with either 70 nM of YM201636 inhibitor
or DMSO, as control. MAG (myelin associated glycoprotein) is
not decreased in YM201636 treated cultures, showing that
treatment with the compound does not affect myelination. (C,
D) Western blot analysis of FIG4 on a GST-pull down assay
performed using recombinant GST-MTMR2 on extracts from
total brain (C) and isolated rat Schwann cells (D). Dlg1 was
detected in the Schwann cell lysate and used as a positive control
for the GST-MTMR2 pull down. Note that Fig4 binds not
specifically to GST and/or Sepharose beads. (E) Comassie gel
showing the quality and the amount of recombinant GST-
MTMR2 and GST control.
(TIF)
Table S1 PI measurements from wild-type yeast strains
transformed with FLAG-MTMR2. Values listed are the percent
of total phosphatidylinositol. Values for two independent exper-
iments, as well as the averages (Avg) for each time point are
presented.
(DOC)
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